Mari-Liis L.
- Country
- Estonia
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 14 of 77 partner sites.
Specializations
Atopic Dermatitis
Mari-Liis Laanetu is involved in clinical research focused on moderate to severe atopic dermatitis, with attention to patients who require systemic therapy. This area centers on improving control of inflammatory skin disease in both adolescent and adult populations.
- Inflammatory skin disease
- Systemic treatment candidates
- Adolescent and adult dermatology
Her work in this field is linked to the evaluation of targeted dermatologic therapies for persistent eczema symptoms and disease burden.
Major Depressive Disorder
Her clinical trial activity also includes major depressive disorder, with a therapeutic focus on maintaining symptom control after initial response to treatment. The research landscape reflects interest in adjunctive psychiatric therapy for adults living with depressive illness.
- Depressive symptom relapse prevention
- Adjunctive treatment in MDD
- Long-term psychiatric care
This area highlights involvement in treatment strategies aimed at sustaining benefit in patients with ongoing mood disorder management needs.
Psychiatric Safety and Tolerability
A further research interest is the long-term safety and tolerability of therapies used as add-on treatment in major depressive disorder. This domain emphasizes the clinical monitoring of treatment persistence and patient acceptability in psychiatric practice.
- Long-term treatment safety
- Tolerability assessment
- Adult depression management
The investigator’s portfolio includes care areas where sustained use of psychiatric therapy and symptom stability are central therapeutic goals.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.